UBS Group AG - NEUROBO PHARMACEUTICALS INC ownership

NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 32 filers reported holding NEUROBO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,000
-90.0%
3,066
-72.8%
0.00%
Q1 2022$10,000
+150.0%
11,253
+985.1%
0.00%
Q3 2021$4,000
-60.0%
1,037
-64.0%
0.00%
Q2 2021$10,000
-23.1%
2,881
+1.4%
0.00%
Q1 2021$13,000
+160.0%
2,841
+201.0%
0.00%
Q4 2020$5,000
-54.5%
944
-50.7%
0.00%
Q3 2020$11,000
-21.4%
1,913
+8.2%
0.00%
Q2 2020$14,000
+100.0%
1,768
+126.1%
0.00%
Q4 2019$7,0007820.00%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 93,376$45,0000.03%
Murchinson Ltd. 205,256$98,0000.02%
Mount Yale Investment Advisors, LLC 57,425$28,0000.00%
TWO SIGMA SECURITIES, LLC 40,496$19,0000.00%
UBS Group AG 3,066$1,0000.00%
BANK OF AMERICA CORP /DE/ 240$00.00%
WELLS FARGO & COMPANY/MN 356$00.00%
NORTHERN TRUST CORP 17,155$8,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 438$00.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders